Zhou et al. revealed the miR-365–HOXA9–HIF-1α regulatory axis, which promotes glycolysis in cutaneous squamous cell carcinoma (cSCC) and provides a potential target for intervention in cSCC therapy [106]. This evidence concerns the gene HIF1A and skin squamous cell carcinoma.